Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfredo Addeo

Showing results (131-140 of 224) with videos related to

Pageof 23
Sort By:
Targeted Oncology|January 12, 2020
Immune Checkpoint Inhibitor-Induced Pancreatic Injury: Imaging Findings and Literature ReviewMichele Porcu, Cinzia Solinas, Cristina Migali, et al.
Anticancer Research|August 28, 2004
A phase II trial of weekly paclitaxel and gemcitabine in non-small cell lung cancer patients previously treated with platinum and vinorelbineVincenzo Dongiovanni, Alfredo Addeo, Alfredo Berruti, et al.
Pharmacology & Therapeutics|January 12, 2023
RET aberrant cancers and RET inhibitor therapies: Current state-of-the-art and future perspectivesAlfredo Addeo, Ernesto Miranda-Morales, Petra den Hollander, et al.
Cancers|December 9, 2023
An Optimized Method to Culture Human Primary Lung Tumor Cell SpheroidsAmanda Mueggler, Eléa Pilotto, Nadja Perriraz-Mayer, et al.
International Journal of Oncology|May 9, 2009
Impact of surgery and chemotherapy on cellular immunity in pancreatic carcinoma patients in view of an integration of standard cancer treatment with immunotherapyGraziella Bellone, Anna Novarino, Barbara Vizio, et al.
Lung Cancer (Amsterdam, Netherlands)|January 11, 2005
Sequential chemotherapy of cisplatin and vinorelbine followed by paclitaxel and gemcitabine in advanced non-small-cell lung cancer. A single institution phase II studyDiego Dongiovanni, Camilla Fissore, Alfredo Berruti, et al.
BMC Palliative Care|December 10, 2017
Exploring the characteristics of patients with mesothelioma who chose active symptom control over chemotherapy as first-line treatment: a prospective, observational, single centre studyAnna C Bibby, Duneesha De Fonseka, Anna J Morley, et al.
Expert Review of Respiratory Medicine|January 31, 2024
First-line immunotherapy in non-small cell lung cancer: how to select and where to goAndrea Mogavero, Ornella Cantale, Veronica Mollica, et al.
JAMA Network Open|April 16, 2024
Neoadjuvant Chemo-Immunotherapy for Early-Stage Non-Small Cell Lung Cancer: A Systematic Review and Meta-AnalysisGiuseppe Luigi Banna, Mona Ali Hassan, Alessio Signori, et al.
Plos One|March 22, 2019
Anticoagulant therapy for acute venous thrombo-embolism in cancer patients: A systematic review and network meta-analysisAnne Rossel, Helia Robert-Ebadi, Christophe Combescure, et al.
Pageof 23

Showing results (131-140 of 224) with videos related to

Sort By:
Pageof 23
Targeted Oncology|January 12, 2020
Immune Checkpoint Inhibitor-Induced Pancreatic Injury: Imaging Findings and Literature ReviewMichele Porcu, Cinzia Solinas, Cristina Migali, et al.
Anticancer Research|August 28, 2004
A phase II trial of weekly paclitaxel and gemcitabine in non-small cell lung cancer patients previously treated with platinum and vinorelbineVincenzo Dongiovanni, Alfredo Addeo, Alfredo Berruti, et al.
Pharmacology & Therapeutics|January 12, 2023
RET aberrant cancers and RET inhibitor therapies: Current state-of-the-art and future perspectivesAlfredo Addeo, Ernesto Miranda-Morales, Petra den Hollander, et al.
Cancers|December 9, 2023
An Optimized Method to Culture Human Primary Lung Tumor Cell SpheroidsAmanda Mueggler, Eléa Pilotto, Nadja Perriraz-Mayer, et al.
International Journal of Oncology|May 9, 2009
Impact of surgery and chemotherapy on cellular immunity in pancreatic carcinoma patients in view of an integration of standard cancer treatment with immunotherapyGraziella Bellone, Anna Novarino, Barbara Vizio, et al.
Lung Cancer (Amsterdam, Netherlands)|January 11, 2005
Sequential chemotherapy of cisplatin and vinorelbine followed by paclitaxel and gemcitabine in advanced non-small-cell lung cancer. A single institution phase II studyDiego Dongiovanni, Camilla Fissore, Alfredo Berruti, et al.
BMC Palliative Care|December 10, 2017
Exploring the characteristics of patients with mesothelioma who chose active symptom control over chemotherapy as first-line treatment: a prospective, observational, single centre studyAnna C Bibby, Duneesha De Fonseka, Anna J Morley, et al.
Expert Review of Respiratory Medicine|January 31, 2024
First-line immunotherapy in non-small cell lung cancer: how to select and where to goAndrea Mogavero, Ornella Cantale, Veronica Mollica, et al.
JAMA Network Open|April 16, 2024
Neoadjuvant Chemo-Immunotherapy for Early-Stage Non-Small Cell Lung Cancer: A Systematic Review and Meta-AnalysisGiuseppe Luigi Banna, Mona Ali Hassan, Alessio Signori, et al.
Plos One|March 22, 2019
Anticoagulant therapy for acute venous thrombo-embolism in cancer patients: A systematic review and network meta-analysisAnne Rossel, Helia Robert-Ebadi, Christophe Combescure, et al.
Pageof 23